Frequent Missed Opportunities for Earlier Diagnosis of Advanced-Stage Colorectal or Lung Cancer
JAMA Internal Medicine 10.1001/jamainternmed.2025.2875July 21, 2025 at 11:00 AM EDT
What is the association between a digital quality measure for advanced-stage cancer and prior missed opportunities for cancer diagnosis?In this cohort study of 37 691 patients from the Department of Veterans Affairs (VA) health system and 2914 patients from Geisinger Health System with lung cancer and 14 674 patients from the VA health system and 627 patients from Geisinger with colorectal cancer, the proportion of advanced-stage lung cancer was 45.9% at the VA health system and 58.3% at Geisinger, with frequent missed opportunities (58.9% and 77.8%, respectively). The proportion of advanced-stage colorectal cancer was 33.2% at the VA health system and 36.2% at Geisinger, and most patients had missed opportunities (66.3% and 69.7%, respectively); median diagnostic delays in the cohort ranged from 1 to 20 months.This study found that an advanced-stage cancer digital quality measure can help health systems measure preventable delays in cancer diagnosis.
Link to the article in your story
We encourage you to link out to this article in your your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.